Skip to main content

Table 1 Subgroup specification of BLCA patients with WWOX, TFAP2A and TFAP2C expression levels

From: In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer

Group Number of patients WWOX TFAP2A TFAP2C
A 58 Low High High
B 84 Low Low Low
C 37 High High High
D 38 High Low Low
E 24 High High Low
F 47 High Low High
G 39 Low High Low
H 81 Low Low High
\